前收市價 | 13.00 |
開市 | 13.00 |
買盤 | 0.00 |
賣出價 | 0.00 |
拍板 | 2.50 |
到期日 | 2025-01-17 |
今日波幅 | 13.00 - 13.00 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 311 |
Shares of the vaccine maker are trading up 230% this year.
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains. Drug manufacturers have been waiting on approval from the agency, whose decision-making was complicated by the fact that the virus keeps mutating. FDA settled on targeting JN.1 — the variant responsible for most Covid cases of early this year. A vaccine targeting JN. 1 should offer broader protection against its offshoots KP.2, KP.3 and others t